As of 2025-09-18, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 13.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.34 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 220.8%.
The range of the Relative Valuation is 8.14 - 19.83 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 20.6x | 18.1x |
| Forward P/E multiples | 17.0x - 26.6x | 21.8x |
| Fair Price | 8.14 - 19.83 | 13.92 |
| Upside | 87.5% - 357.0% | 220.8% |
| Date | P/E |
| 2025-09-17 | 4.51 |
| 2025-09-16 | 4.70 |
| 2025-09-15 | 4.82 |
| 2025-09-12 | 4.65 |
| 2025-09-11 | 4.68 |
| 2025-09-10 | 4.72 |
| 2025-09-09 | 4.90 |
| 2025-09-08 | 4.74 |
| 2025-09-05 | 5.23 |
| 2025-09-04 | 5.31 |
| 2025-09-03 | 5.33 |
| 2025-09-02 | 5.31 |
| 2025-08-29 | 5.24 |
| 2025-08-28 | 5.17 |
| 2025-08-27 | 5.30 |
| 2025-08-26 | 5.39 |
| 2025-08-25 | 5.19 |
| 2025-08-22 | 5.46 |
| 2025-08-21 | 5.43 |
| 2025-08-20 | 5.31 |
| 2025-08-19 | 5.29 |
| 2025-08-18 | 5.20 |
| 2025-08-15 | 5.96 |
| 2025-08-14 | 5.53 |
| 2025-08-13 | 5.51 |
| 2025-08-12 | 5.06 |
| 2025-08-11 | 5.04 |
| 2025-08-08 | 3.84 |
| 2025-08-07 | 3.42 |
| 2025-08-06 | 3.38 |
| 2025-08-05 | 3.35 |
| 2025-08-04 | 3.31 |
| 2025-08-01 | 3.19 |
| 2025-07-31 | 3.23 |
| 2025-07-30 | 3.29 |
| 2025-07-29 | 3.31 |
| 2025-07-28 | 3.47 |
| 2025-07-25 | 3.41 |
| 2025-07-24 | 3.53 |
| 2025-07-23 | 3.59 |
| 2025-07-22 | 3.61 |
| 2025-07-21 | 3.55 |
| 2025-07-18 | 3.53 |
| 2025-07-17 | 3.49 |
| 2025-07-16 | 3.58 |
| 2025-07-15 | 3.60 |
| 2025-07-14 | 3.59 |
| 2025-07-11 | 3.52 |
| 2025-07-10 | 3.66 |
| 2025-07-09 | 3.74 |